Westfield, NJ, United States of America

Paul J Reider


Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 96(Granted Patents)


Location History:

  • Rahway, NJ (US) (2002)
  • Westfield, NJ (US) (1986 - 2003)

Company Filing History:


Years Active: 1986-2003

Loading Chart...
29 patents (USPTO):

Title: **Paul J Reider: Innovator in Pharmaceutical Sciences**

Introduction

Paul J Reider, based in Westfield, NJ, is a prolific inventor with an impressive portfolio comprising 29 patents. His contributions to the field of pharmaceutical sciences have significantly advanced the development of therapeutic treatments, especially those concerning HMG-CoA reductase inhibitors.

Latest Patents

Among his notable patents are the "Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors." This invention outlines methods and pharmaceutical compositions aimed at inhibiting HMG-CoA reductase. The invention presents a formulation that allows for oral administration of a therapeutically effective compound, selected from a dihydroxy open acid statin or its pharmaceutically acceptable salts or esters, in a delayed-release dosage form. This innovative approach ensures that substantial release of the compound occurs after the dosage form has passed through the stomach, thereby optimizing its therapeutic efficacy. Another patent focuses on the "Process for the synthesis of carbapenem intermediates and compounds produced," showcasing his expertise in the synthesis of complex pharmaceutical compounds.

Career Highlights

Paul Reider's professional journey includes significant stints at Merck & Company, Inc. His experience in such a leading pharmaceutical company has played a crucial role in shaping his innovative approaches and enhancing his impact on the industry.

Collaborations

Throughout his career, Paul has collaborated with notable professionals such as Ralph P Volante and Kai Rossen. These collaborations have not only enriched his research but have also contributed to the advancement of knowledge in the field of pharmaceuticals.

Conclusion

In summary, Paul J Reider epitomizes the spirit of innovation in the pharmaceutical sector. With his extensive patent portfolio and invaluable contributions to the development of effective drug formulations, he continues to inspire future generations of inventors and researchers in the field. His work exemplifies the importance of innovation in addressing complex health issues and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…